Magnetic resonance imaging/ultrasound–fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy MM Siddiqui, S Rais-Bahrami, H Truong, L Stamatakis, S Vourganti, J Nix, ... European urology 64 (5), 713-719, 2013 | 581 | 2013 |
Oral relugolix for androgen-deprivation therapy in advanced prostate cancer ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ... New England Journal of Medicine 382 (23), 2187-2196, 2020 | 359 | 2020 |
Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies S Vourganti, A Rastinehad, NK Yerram, J Nix, D Volkin, A Hoang, ... The Journal of urology 188 (6), 2152-2157, 2012 | 293 | 2012 |
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (6), 748-758, 2021 | 278 | 2021 |
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer L Stamatakis, MM Siddiqui, JW Nix, J Logan, S Rais‐Bahrami, ... Cancer 119 (18), 3359-3366, 2013 | 234 | 2013 |
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management B Shuch, S Vourganti, CJ Ricketts, L Middleton, J Peterson, MJ Merino, ... Journal of clinical oncology 32 (5), 431-437, 2014 | 221 | 2014 |
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer S Rais-Bahrami, MM Siddiqui, B Turkbey, L Stamatakis, J Logan, ... The Journal of urology 190 (5), 1721-1727, 2013 | 199 | 2013 |
Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity M Mollapour, S Tsutsumi, AW Truman, W Xu, CK Vaughan, K Beebe, ... Molecular cell 41 (6), 672-681, 2011 | 190 | 2011 |
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate‐specific antigen (PSA)‐based detection of prostate cancer in men without prior biopsies S Rais‐Bahrami, MM Siddiqui, S Vourganti, B Turkbey, AR Rastinehad, ... BJU international 115 (3), 381-388, 2015 | 155 | 2015 |
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high‐risk prostate cancer NK Yerram, D Volkin, B Turkbey, J Nix, AN Hoang, S Vourganti, GN Gupta, ... BJU international 110 (11b), E783-E788, 2012 | 114 | 2012 |
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? A Walton Diaz, AN Hoang, B Turkbey, CW Hong, H Truong, T Sterling, ... The Journal of urology 190 (6), 2020-2025, 2013 | 100 | 2013 |
Overall survival advantage with partial nephrectomy: a bias of observational data? B Shuch, J Hanley, J Lai, S Vourganti, SP Kim, CM Setodji, AW Dick, ... Cancer 119 (16), 2981-2989, 2013 | 99 | 2013 |
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma B Shuch, G Bratslavsky, J Shih, S Vourganti, D Finley, B Castor, E Treat, ... BJU international 109 (11), 1600-1606, 2012 | 99 | 2012 |
Ultrasonographic evaluation of renal infections S Vourganti, PK Agarwal, DR Bodner, VS Dogra Radiologic Clinics 44 (6), 763-775, 2006 | 94 | 2006 |
Epidermal growth factor receptor (EGFR)-targeted photoimmunotherapy (PIT) for the treatment of EGFR-expressing bladder cancer R Railkar, LS Krane, QQ Li, T Sanford, MR Siddiqui, D Haines, ... Molecular cancer therapeutics 16 (10), 2201-2214, 2017 | 91 | 2017 |
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma S Roychowdhury, R Peng, RA Baiocchi, D Bhatt, S Vourganti, J Grecula, ... Cancer research 63 (5), 965-971, 2003 | 89 | 2003 |
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up S Rais-Bahrami, B Türkbey, AR Rastinehad, A Walton-Diaz, AN Hoang, ... Diagnostic and interventional radiology 20 (4), 293, 2014 | 71 | 2014 |
GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder RA Baiocchi, JS Ward, L Carrodeguas, CF Eisenbeis, R Peng, ... The Journal of clinical investigation 108 (6), 887-894, 2001 | 69 | 2001 |
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8+ T-cell restoration P Porcu, CF Eisenbeis, RP Pelletier, EA Davies, RA Baiocchi, ... Blood, The Journal of the American Society of Hematology 100 (7), 2341-2348, 2002 | 66 | 2002 |
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. B Turkbey, R Huang, S Vourganti, H Trivedi, M Bernardo, P Yan, ... BJU international 110 (11), 2012 | 65 | 2012 |